CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding ...

So, I’m mildly freaking out,” Margaret Lawson wrote from St Andrew’s Hospital where, having not been able to get an appointment with a GP, she’d gone to ask for a CT scan for a lingering headache.

Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Outcomes4Me Inc., the developer of the first direct-to-patient, personalized, and evidence-based cancer navigation platform, and the National ...

Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

ArriVent BioPharma, Inc. ( (AVBP) ) has released its Q3 earnings. Here is a breakdown of the information ArriVent BioPharma, Inc. presented to ...